AR008245A1 - Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados - Google Patents
Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivadosInfo
- Publication number
- AR008245A1 AR008245A1 ARP970102676A ARP970102676A AR008245A1 AR 008245 A1 AR008245 A1 AR 008245A1 AR P970102676 A ARP970102676 A AR P970102676A AR P970102676 A ARP970102676 A AR P970102676A AR 008245 A1 AR008245 A1 AR 008245A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- prepare
- manufacture
- acetic acid
- therapeutic agent
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 2
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008245A1 true AR008245A1 (es) | 1999-12-29 |
Family
ID=27268341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970102676A AR008245A1 (es) | 1996-06-21 | 1997-06-18 | Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0912555A1 (cs) |
JP (1) | JP2000512648A (cs) |
KR (1) | KR20000022041A (cs) |
AP (1) | AP9801417A0 (cs) |
AR (1) | AR008245A1 (cs) |
AU (1) | AU3261197A (cs) |
BR (1) | BR9709930A (cs) |
CA (1) | CA2258753A1 (cs) |
CZ (1) | CZ424698A3 (cs) |
EA (1) | EA199801015A1 (cs) |
ID (1) | ID17052A (cs) |
IL (1) | IL127464A0 (cs) |
IS (1) | IS4924A (cs) |
NO (1) | NO985974L (cs) |
PL (1) | PL330797A1 (cs) |
TR (1) | TR199802665T2 (cs) |
WO (1) | WO1997049699A1 (cs) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
WO2003004488A1 (en) | 2001-07-03 | 2003-01-16 | Chiron Corporation | Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
TW200505904A (en) * | 2003-02-14 | 2005-02-16 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
CA2648055A1 (en) | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
AU2008204583A1 (en) | 2007-01-10 | 2008-07-17 | F. Hoffmann-La Roche Ag | Sulfonamide derivatives as chymase inhibitors |
CN113655155A (zh) * | 2021-07-28 | 2021-11-16 | 任贤金 | 一种测定sph3127有关物质的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
EP0612313A1 (en) * | 1991-11-14 | 1994-08-31 | Glaxo Group Limited | Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
-
1997
- 1997-06-18 AR ARP970102676A patent/AR008245A1/es unknown
- 1997-06-19 KR KR1019980710439A patent/KR20000022041A/ko not_active Withdrawn
- 1997-06-19 WO PCT/EP1997/003196 patent/WO1997049699A1/en not_active Application Discontinuation
- 1997-06-19 PL PL97330797A patent/PL330797A1/xx unknown
- 1997-06-19 BR BR9709930A patent/BR9709930A/pt not_active Application Discontinuation
- 1997-06-19 CA CA002258753A patent/CA2258753A1/en not_active Abandoned
- 1997-06-19 EA EA199801015A patent/EA199801015A1/ru unknown
- 1997-06-19 JP JP10502284A patent/JP2000512648A/ja active Pending
- 1997-06-19 EP EP97928243A patent/EP0912555A1/en not_active Withdrawn
- 1997-06-19 CZ CZ984246A patent/CZ424698A3/cs unknown
- 1997-06-19 ID IDP972092A patent/ID17052A/id unknown
- 1997-06-19 AP APAP/P/1998/001417A patent/AP9801417A0/en unknown
- 1997-06-19 AU AU32611/97A patent/AU3261197A/en not_active Abandoned
- 1997-06-19 IL IL12746497A patent/IL127464A0/xx unknown
- 1997-06-19 TR TR1998/02665T patent/TR199802665T2/xx unknown
-
1998
- 1998-12-15 IS IS4924A patent/IS4924A/is unknown
- 1998-12-18 NO NO985974A patent/NO985974L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IS4924A (is) | 1998-12-15 |
JP2000512648A (ja) | 2000-09-26 |
AU3261197A (en) | 1998-01-14 |
AP9801417A0 (en) | 1998-12-31 |
NO985974D0 (no) | 1998-12-18 |
CA2258753A1 (en) | 1997-12-31 |
EP0912555A1 (en) | 1999-05-06 |
NO985974L (no) | 1999-02-17 |
IL127464A0 (en) | 1999-10-28 |
EA199801015A1 (ru) | 1999-08-26 |
BR9709930A (pt) | 1999-08-10 |
WO1997049699A1 (en) | 1997-12-31 |
KR20000022041A (ko) | 2000-04-25 |
TR199802665T2 (xx) | 1999-03-22 |
CZ424698A3 (cs) | 1999-05-12 |
ID17052A (id) | 1997-12-04 |
PL330797A1 (en) | 1999-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
UA41297C2 (uk) | Похідні індолу, фармацевтична композиція і спосіб лікування | |
ES2123654T3 (es) | Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos. | |
DK1140745T3 (da) | Colchinolderivater som vaskulært skadelige midler | |
ES8604565A1 (es) | Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico | |
SE7614258L (sv) | Forfarande for framstellning av kinazoloderivat | |
LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
MX9204637A (es) | Nuevos derivados de pirazina y procedimiento para su preparacion. | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
AR008245A1 (es) | Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados | |
BG101605A (bg) | Ентерокинетични бензамиди | |
ES427079A1 (es) | Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7. | |
HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
ES2093246T3 (es) | Compuestos de benzazepina terapeuticos. | |
RU95101437A (ru) | Содержащее производные 3-фенилсульфонил-3,7-диазабицикло [3,3,1] нонана лекарственное средство, способ получения производных 3-фенилсульфонил-3,7-диазабицикло-[3,3,1]-нонана | |
DK527186A (da) | Bronchodilaterende farmaceutisk praeparat | |
ES478984A1 (es) | Procedimiento de preparacion de productos del grupo de la e-burnamenina. | |
GT199900171A (es) | Concentrado oral de sertralina. | |
ES8802612A1 (es) | Procedimiento para preparar derivados de benzisoselenazolilo | |
SE9900190D0 (sv) | New compounds | |
DK0541726T3 (da) | Vækstfaktorsammensætninger, fremstilling og anvendelse | |
SE8402199L (sv) | Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist | |
AR005724A1 (es) | Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple |